| BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax VS Lin, TE Lew, SM Handunnetti, P Blombery, T Nguyen, DA Westerman, ... Blood, The Journal of the American Society of Hematology 135 (25), 2266-2270, 2020 | 87 | 2020 |
| Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition TE Lew, VS Lin, ER Cliff, P Blombery, ER Thompson, SM Handunnetti, ... Blood Advances 5 (20), 4054-4058, 2021 | 48 | 2021 |
| Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL P Blombery, TE Lew, MA Dengler, ER Thompson, VS Lin, X Chen, ... Blood, The Journal of the American Society of Hematology 139 (8), 1198-1207, 2022 | 42 | 2022 |
| Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months TE Lew, MA Anderson, VS Lin, SM Handunnetti, NA Came, P Blombery, ... Blood advances 4 (1), 165-173, 2020 | 40 | 2020 |
| Bh3 mimetics for the treatment of b-cell malignancies—insights and lessons from the clinic VS Lin, ZF Xu, DCS Huang, R Thijssen Cancers 12 (11), 3353, 2020 | 16 | 2020 |
| Definitions of massive transfusion in adults with critical bleeding: a systematic review VS Lin, E Sun, S Yau, C Abeyakoon, G Seamer, S Bhopal, H Tucker, ... Critical Care 27 (1), 265, 2023 | 7 | 2023 |
| International forum on the management of major haemorrhage: summary L Green, S Stanworth, Z McQuilten, V Lin, H Tucker, B Jackson, M Badawi, ... Vox Sanguinis, 2022 | 4 | 2022 |
| Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon TE Lew, R Bennett, VS Lin, A Whitechurch, SM Handunnetti, P Marlton, ... Blood Advances 8 (6), 1439-1443, 2024 | 2 | 2024 |
| Venetoclax for the treatment of mantle cell lymphoma VS Lin, MA Anderson, DCS Huang, AW Roberts, JF Seymour, CSL Tam Annals of Lymphoma 3, 2019 | 1 | 2019 |
| International Forum on the Management of Major Haemorrhage: Responses. L Green, S Stanworth, Z McQuilten, V Lin, H Tucker, B Jackson, M Badawi, ... Vox Sanguinis 117 (5), 2022 | | 2022 |
